Analysts Predict Inhibikase Therapeutics Inc (NASDAQ:IKT) To Reach 8 In 12 Months
In last trading session, Inhibikase Therapeutics Inc (NASDAQ:IKT) saw 0.44 million shares changing hands with its beta currently measuring 1.03. Company’s recent per share price